Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.38B |
| 2 |
Microsoft
MSFT
|
+$1.13B |
| 3 |
Amazon
AMZN
|
+$756M |
| 4 |
Tesla
TSLA
|
+$466M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$199M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$191M |
| 3 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$62.8M |
| 4 |
KL
Kirkland Lake Gold Ltd Ordinary
KL
|
+$43.9M |
| 5 |
ATH
Athene Holding Ltd. Class A Common Shares
ATH
|
+$42.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.22% |
| 2 | Healthcare | 14.23% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Communication Services | 9.53% |
| 5 | Industrials | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Tejon Ranch
TRC
$441M
| $911K | ﹤0.01% |
49,880
+3,400
| +7% | +$59.3K |
|
|
VERV
2452
DELISTED
Verve Therapeutics
VERV
| $911K | ﹤0.01% |
39,900
+3,000
| +8% | +$85.7K |
|
2453
Quantum-Si Incorporated
QSI
$182M
| $910K | ﹤0.01% |
194,500
+15,100
| +8% | +$73.6K |
|
2454
Crescent Energy
CRGY
$3.98B
| $908K | ﹤0.01% |
52,380
+4,100
| +8% | +$60.7K |
|
2455
Ituran Location and Control
ITRN
$1.07B
| $905K | ﹤0.01% |
39,325
-2,200
| -5% | -$51.2K |
|
|
PRTY
2456
DELISTED
Party City Holdco Inc.
PRTY
| $903K | ﹤0.01% |
252,100
+18,200
| +8% | +$82.4K |
|
2457
Funko
FNKO
$331M
| $897K | ﹤0.01% |
52,000
+4,300
| +9% | +$75.1K |
|
|
STKL
2458
DELISTED
SunOpta
STKL
| $897K | ﹤0.01% |
178,725
+14,300
| +9% | +$75.4K |
|
|
DCPH
2459
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $897K | ﹤0.01% |
96,800
+7,200
| +8% | +$61.2K |
|
2460
Universal Insurance Holdings
UVE
$1.18B
| $896K | ﹤0.01% |
66,400
+4,500
| +7% | +$67.5K |
|
2461
IES Holdings
IESC
$15.3B
| $892K | ﹤0.01% |
22,200
+1,600
| +8% | +$72.2K |
|
2462
Nano X Imaging
NNOX
$71M
| $865K | ﹤0.01% |
79,800
+6,500
| +9% | +$69.4K |
|
2463
4D Molecular Therapeutics
FDMT
$621M
| $862K | ﹤0.01% |
57,000
+3,700
| +7% | +$58.1K |
|
|
MLNK
2464
DELISTED
MeridianLink
MLNK
| $862K | ﹤0.01% |
47,600
+3,400
| +8% | +$63.4K |
|
2465
Five Point Holdings
FPH
$372M
| $861K | ﹤0.01% |
140,900
+11,500
| +9% | +$70.4K |
|
2466
Humacyte
HUMA
$179M
| $860K | ﹤0.01% |
121,800
+8,400
| +7% | +$48.9K |
|
2467
Skywest
SKYW
$4.16B
| $860K | ﹤0.01% |
29,800
+2,100
| +8% | +$68.6K |
|
2468
Anika Therapeutics
ANIK
$295M
| $859K | ﹤0.01% |
34,200
+2,400
| +8% | +$73.2K |
|
|
CTLP
2469
DELISTED
Cantaloupe
CTLP
| $852K | ﹤0.01% |
125,800
+8,300
| +7% | +$63K |
|
2470
Ocular Therapeutix
OCUL
$2.25B
| $852K | ﹤0.01% |
172,100
+12,100
| +8% | +$67.1K |
|
2471
Atlanticus Holdings
ATLC
$1.48B
| $849K | ﹤0.01% |
16,400
| – | – |
|
2472
KRONOS Worldwide
KRO
$905M
| $849K | ﹤0.01% |
54,700
+3,800
| +7% | +$56.5K |
|
2473
Centrus Energy
LEU
$3.69B
| $849K | ﹤0.01% |
25,200
+1,800
| +8% | +$75.6K |
|
2474
Replimune Group
REPL
$1.28B
| $847K | ﹤0.01% |
49,900
+3,800
| +8% | +$71.7K |
|
2475
Omeros
OMER
$992M
| $844K | ﹤0.01% |
140,500
+9,600
| +7% | +$59.9K |
|
Similar funds
Swiss National Bank's Q1 2022 Portfolio in Review
As of Q1 2022, Swiss National Bank held 2,722 positions worth $177B, up 6.8% from $166B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Swiss National Bank deployed $20.2B of net new capital in Q1 2022, opening 3 new positions and adding to 2,642 existing holdings. Its largest new stake was Constellation Energy: 1,411,783 shares worth $79.4M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Exelon, an estimated $41.2M trimmed.
- Swiss National Bank's largest Q1 2022 buy was Constellation Energy: 1,411,783 shares worth $79.4M.
- Swiss National Bank added most to Apple in Q1 2022, an estimated $1.38B increase.
- Swiss National Bank's biggest Q1 2022 reduction was Exelon, cutting an estimated $41.2M.
- Swiss National Bank fully exited Xilinx Inc in Q1 2022, selling an estimated $199M.
- Swiss National Bank's ten largest holdings make up 28% of its $177B portfolio in Q1 2022.
- Swiss National Bank opened 3 new positions and closed 31 in Q1 2022.
- Swiss National Bank's portfolio value rose 6.8% quarter-over-quarter to $177B.
Based on Swiss National Bank's 13F filing for Q1 2022, filed 9 May 2022.